spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  APP Pharmaceuticals 

 HSMN NewsFeed - 23 May 2012
APP Pharmaceuticals Acquires Three Products from Nexus
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 3 Oct 2011
The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With Teva
Biopharmaceuticals Litigation
 HSMN NewsFeed - 26 Mar 2011
APP Pharmaceuticals Issues a Nationwide Voluntary Recall of Irinotecan Hydrochloride Injection
Biopharmaceuticals Oncology Product Recall
 HSMN NewsFeed - 26 Jan 2011
APP Pharmaceuticals Announces Agreement with Teva Pharmaceuticals to Manufacture and Market Gemcitabine HCI for Injection
Biopharmaceuticals Licensing Oncology
 HSMN NewsFeed - 30 Oct 2010
APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 Jun 2010
APP Pharmaceuticals to Market Anastrozole Tablets in the U.S.
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Jun 2010
APP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 11 Jun 2010
APP Pharmaceuticals to Market Oxaliplatin Injection (Liquid) in the U.S.
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Mar 2010
APP Pharmaceuticals Receives Approval for Indomethacin for Injection
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Jan 2010
Abraxis BioScience Confirms Plan to Spin-off Abraxis Health in 2010 and Announces Management Structure
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2009
Thomas H. Silberg to Retire as President and CEO of APP Pharmaceuticals, John Ducker Named as Successor
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Aug 2009
APP Pharmaceuticals Receives Approval for Penicillin G Potassium for Injection, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Aug 2009
APP Pharmaceuticals Receives Approval for Idarubicin HCI Injection
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Sep 2008
APP Pharmaceuticals Announces Completion of Acquisition by Fresenius
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 2 Sep 2008
APP Pharmaceuticals and Fresenius Announce Clearance of APP Acquisition by U.S. Federal Trade Commission
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Jul 2008
APP Pharmaceuticals to Be Acquired by Fresenius
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Jul 2008
APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Apr 2008
APP Pharmaceuticals Names Thomas H. Silberg Chief Executive Officer; Appoints Richard J. Tajak Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Apr 2008
APP Pharmaceuticals Receives FDA Approval for Colistimethate For Injection, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Mar 2008
APP Pharmaceuticals Launches Cefepime Hydrochloride for Injection
Biopharmaceuticals Generics
 HSMN NewsFeed - 27 Feb 2008
APP Pharmaceuticals Receives Final Approval for Irinotecan Hydrochloride Injection
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 8 Feb 2008
APP Pharmaceuticals Receives FDA Approval for Bleomycin Sulfate for Injection, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 8 Feb 2008
APP Pharmaceuticals Receives FDA Approval for Caffeine Citrate Oral Solution, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 Jan 2008
APP Pharmaceuticals Receives FDA Approval for Polymyxin B Sulfate for Injection, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 8 Nov 2007
Abraxis BioScience Announces the Closing Date for the Separation of Its Proprietary Business from Its Hospital-Based Business
Biopharmaceuticals
 HSMN NewsFeed - 5 Oct 2007
APP Receives Tentative FDA Approval for Irinotecan Hydrochloride Injection, 20 mg/mL Packaged in 2 mL and 5 mL Single-Use Vials
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Feb 2007
Javelin Pharmaceuticals Names Derek Gallacher as European Managing Director
Biopharmaceuticals Personnel
Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!